Job title: Executive Director
Samantha’s experience spans portfolio & product development and strategy, launch planning, operations and corporate culture. Prior to Biogen she was Vice President, Head of Programme Management at Nightstar Therapeutics, having joined Nightstar in early 2015 as one of the first employees and a member of the management team.
Prior to Nightstar Samantha spent just over 10 years in research and development having held positions of increasing responsibility at Emergent BioSolutions within programme management/leadership and Lonza Biologics in process development.
Samantha has an MBA from Henley Business School, UK and a Bachelor of Science Degree (with honours) from University of Witwatersrand, South Africa.
PANEL DISCUSSION: Evaluating the Current Commercial Landscape in Light of a Recent Ophthalmic Approval 12:30 pm
Exciting work is being done to develop gene therapies to treat a variety of ophthalmic disorders, and there is already a retinal gene therapy on the market. This leads to key questions surrounding reimbursement, access to therapies, and effective commercialization and product differentiation of gene therapies to come. This panel discussion will address various topics…Read more
day: Day Two
Determining the Right Site for Your Gene Therapy Trial 11:30 am
• Understanding unique needs of the trial and cross-checking against potential trial sites • Exploring relevant importance of both ophthalmic expertise and gene therapy expertise • Investigating scaling capabilities of different sites • Discussing collaboration between the sponsor, site, and investigatorRead more
day: Day Two